The Biology of Ankyrin-B: The Heart's Electrical Anchor
At a Glance
Ankyrin-B syndrome is an ANK2-related heart-rhythm disorder in which a disrupted cellular support structure affects proteins that control sodium and calcium. Because each variant and person can differ, symptoms may range from a slow heart rate or atrial fibrillation to a long QT interval or no symptoms.
To understand Ankyrin-B syndrome, it helps to think of a heart cell as a complex construction site. For the heart to beat correctly, thousands of tiny “tools”—called ion channels and pumps—must be bolted into exactly the right spots on the cell’s surface [1]. The ANK2 gene provides the instructions for building a protein called Ankyrin-B, which acts as the “scaffolding” or “anchor” that holds these tools in place [2][3].
In many disease-associated variants of Ankyrin-B syndrome, this scaffolding is reduced or disrupted. This is often known as a loss-of-function variant [1]. When the scaffolding fails, the heart’s electrical tools can become disorganized, leading to a variety of rhythm problems that can look different from one person to the next [4].
The Job of the “Anchor”
Ankyrin-B’s primary job is to coordinate main components that manage the electricity in your heart cells. While research in laboratories and animal models has shown interactions with various pumps and calcium regulators, these mechanisms are highly dependent on the specific variant.
- The Sodium-Potassium Pump (Na/K ATPase): This pump maintains the basic electrical charge of the cell [2].
- The Sodium-Calcium Exchanger (NCX1): This tool uses the sodium gradient to pump excess calcium out of the cell [2][5].
- Calcium Regulators (RyR2 and PP2A): These help control the release of calcium, which is what actually makes the heart muscle contract [6][7].
When Ankyrin-B is working correctly, these tools work in a timed loop. When it is disrupted, the cell can sometimes become “overloaded” with calcium. This extra calcium can cause the cell to “fire” an electrical signal when it isn’t supposed to, leading to an irregular heartbeat [2][8]. Note that not every ANK2 variant produces the exact same cellular defect.
Why It’s Not “Typical” Long QT
You may hear Ankyrin-B syndrome called Long QT Syndrome Type 4 (LQT4), but this name can be misleading. In “classic” Long QT Syndrome (Types 1, 2, or 3), the analogy is usually a broken “door” (a single ion channel) [9]. In Ankyrin-B syndrome, the doors themselves might be fine, but they are bolted to the wrong part of the wall or are missing their support beams [4][3].
Because the problem is with the scaffolding rather than a single door, the symptoms are much broader:
- Sinus Node Dysfunction: The heart’s natural pacemaker may slow down because its “anchors” aren’t holding the right signals in place [9][10].
- Conduction Block: Electrical signals may get “lost” or delayed as they travel through the heart’s chambers [3].
- Atrial Fibrillation: The upper chambers of the heart may become electrically unstable, leading to a fast, irregular rhythm [11].
Distinguishing It from Other Conditions
Ankyrin-B syndrome is a “chameleon” condition because its biology can sometimes mimic other better-known heart disorders [10]:
- Classic LQTS: Typically involves a defect in a single channel that resets the heart’s charge [9]. Ankyrin-B affects the placement of multiple pumps and exchangers [4].
- CPVT: Involves “leaky” calcium channels that react poorly to adrenaline [12]. Ankyrin-B can cause calcium leaks, but it’s due to a lack of scaffolding, not just a broken channel [6].
- Brugada Syndrome: An electrical syndrome characterized by right-precordial patterns on an ECG, often involving sodium-channel function [13]. Ankyrin-B syndrome can occasionally involve sodium channels, but they are distinct conditions [3].
The Power of Variable Expression
One of the most confusing parts of this biology is variable expression. Because Ankyrin-B is a scaffolding protein that interacts with many different parts of the cell, one person with the variant might only have a slow heart rate, while another might have a long QT interval, and a third might have no symptoms at all [1][14].
Current research suggests that while the ANK2 variant provides the “weak scaffolding,” other factors—like your age, other genes, or even certain medications—determine exactly how that weakness shows up in your heart’s rhythm [15][16]. This is why your doctor will focus on your specific heart tests rather than just the name of the gene [17].
Common questions in this guide
What does an ANK2 variant do in Ankyrin-B syndrome?
Is Ankyrin-B syndrome the same as classic long QT syndrome?
What heart rhythm problems can be linked to ANK2 variants?
Why can people with the same ANK2-related condition have different symptoms?
How is ANK2-related arrhythmia different from CPVT or Brugada syndrome?
Can a resting ECG be normal even if an ANK2 variant affects my heart?
Get notified when new evidence is published on Cardiac arrhythmia, ankyrin-b-related.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (17)
- 1
Novel Variant in the ANK2 Membrane-Binding Domain Is Associated With Ankyrin-B Syndrome and Structural Heart Disease in a First Nations Population With a High Rate of Long QT Syndrome.
Swayne LA, Murphy NP, Asuri S, et al.
Circulation. Cardiovascular genetics 2017; (10(1)) doi:10.1161/CIRCGENETICS.116.001537.
PMID: 28196901 - 2
Coupling of the Na+/K+-ATPase to Ankyrin B controls Na+/Ca2+ exchanger activity in cardiomyocytes.
Skogestad J, Aronsen JM, Tovsrud N, et al.
Cardiovascular research 2020; (116(1)):78-90 doi:10.1093/cvr/cvz087.
PMID: 30949686 - 3
Mechanisms and Alterations of Cardiac Ion Channels Leading to Disease: Role of Ankyrin-B in Cardiac Function.
Sucharski HC, Dudley EK, Keith CBR, et al.
Biomolecules 2020; (10(2)) doi:10.3390/biom10020211.
PMID: 32023981 - 4
The evolving role of ankyrin-B in cardiovascular disease.
Koenig SN, Mohler PJ
Heart rhythm 2017; (14(12)):1884-1889 doi:10.1016/j.hrthm.2017.07.032.
PMID: 28765088 - 5
Identification and characterization of two ankyrin-B isoforms in mammalian heart.
Wu HC, Yamankurt G, Luo J, et al.
Cardiovascular research 2015; (107(4)):466-77 doi:10.1093/cvr/cvv184.
PMID: 26109584 - 6
Ankyrin-B Q1283H Variant Linked to Arrhythmias Via Loss of Local Protein Phosphatase 2A Activity Causes Ryanodine Receptor Hyperphosphorylation.
Zhu W, Wang C, Hu J, et al.
Circulation 2018; (138(23)):2682-2697 doi:10.1161/CIRCULATIONAHA.118.034541.
PMID: 30571258 - 7
Elevated local [Ca2+] and CaMKII promote spontaneous Ca2+ release in ankyrin-B-deficient hearts.
Popescu I, Galice S, Mohler PJ, Despa S
Cardiovascular research 2016; (111(3)):287-94 doi:10.1093/cvr/cvw093.
PMID: 27131508 - 8
Na+ microdomains and sparks: Role in cardiac excitation-contraction coupling and arrhythmias in ankyrin-B deficiency.
Chu L, Greenstein JL, Winslow RL
Journal of molecular and cellular cardiology 2019; (128()):145-157 doi:10.1016/j.yjmcc.2019.02.001.
PMID: 30731085 - 9
Long QT Syndrome and Sinus Bradycardia-A Mini Review.
Wilders R, Verkerk AO
Frontiers in cardiovascular medicine 2018; (5()):106 doi:10.3389/fcvm.2018.00106.
PMID: 30123799 - 10
Phenotypic Variability of ANK2 Mutations in Patients With Inherited Primary Arrhythmia Syndromes.
Ichikawa M, Aiba T, Ohno S, et al.
Circulation journal : official journal of the Japanese Circulation Society 2016; (80(12)):2435-2442 doi:10.1253/circj.CJ-16-0486.
PMID: 27784853 - 11
Mechanisms underlying the role of ankyrin-B in cardiac and neurological health and disease.
York NS, Sanchez-Arias JC, McAdam ACH, et al.
Frontiers in cardiovascular medicine 2022; (9()):964675 doi:10.3389/fcvm.2022.964675.
PMID: 35990955 - 12
Ryanodine receptor 2 mutations in catecholaminergic polymorphic ventricular tachycardia: From molecular mechanisms to precision medicine.
Sharma V
World journal of cardiology 2026; (18(2)):111032 doi:10.4330/wjc.v18.i2.111032.
PMID: 41694040 - 13
Ankyrins and Spectrins in Cardiovascular Biology and Disease.
El Refaey MM, Mohler PJ
Frontiers in physiology 2017; (8()):852 doi:10.3389/fphys.2017.00852.
PMID: 29163198 - 14
High-degree atrioventricular block in a child with an ANK2 variant and long QT phenotype requiring leadless pacemaker implantation.
You J
Cardiology in the young 2026; (36(7)):1532-1535 doi:10.1017/S1047951126123464.
PMID: 42493853 - 15
Common human ANK2 variant confers in vivo arrhythmia phenotypes.
Musa H, Murphy NP, Curran J, et al.
Heart rhythm 2016; (13(9)):1932-40.
PMID: 27298202 - 16
Impact of stress on cardiac phenotypes in mice harboring an ankyrin-B disease variant.
Wallace MJ, Malhotra N, Mariángelo JIE, et al.
The Journal of biological chemistry 2023; (299(6)):104818 doi:10.1016/j.jbc.2023.104818.
PMID: 37182735 - 17
Interpretation and actionability of genetic variants in cardiomyopathies: a position statement from the European Society of Cardiology Council on cardiovascular genomics.
Arbustini E, Behr ER, Carrier L, et al.
European heart journal 2022; (43(20)):1901-1916 doi:10.1093/eurheartj/ehab895.
PMID: 35089333
This page is for informational purposes only and does not constitute medical advice about ANK2-related arrhythmia. A cardiologist or cardiac electrophysiologist should interpret your genetic variant and heart tests in context.